Grants per year
Personal profile
Research Interests
Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.
Certifications and Licenses
| Anatomic Pathology |
Training Experience
| 1994 | Residency, Beth Israel Deaconess Medical Center, Boston |
| 1995 | Fellowship, Beth Israel Deaconess Medical Center, Boston |
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Rush Medical Collage
… → 1990
Medicine, MD, Aristotle University of Thessaloniki
… → 1985
Research interests
- Breast Cancer
- Breast Disease
- Cancer Biology
- Pathology
Fingerprint
Dive into the research topics where Kalliopi P Siziopikou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigating Environmental Risk Factors for Breast Cancer Using Adductomics
Funk, W. E., Goo, Y. A., Kim, K. A. & Siziopikou, K. P.
National Institute of Environmental Health Sciences
3/11/21 → 12/31/25
Project: Research project
-
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
2/4/14 → 5/31/16
Project: Research project
-
Clinicopathologic features of unexpectedly HER2 positive breast carcinomas: An institutional experience
LaBoy, C., Siziopikou, K. P., Rosen, L., Blanco, L. Z. & Pincus, J. L., Jun 2021, In: Pathology Research and Practice. 222, 153441.Research output: Contribution to journal › Article › peer-review
-
The use of serial circulating tumor DNA to detect resistance alterations in progressive metastatic breast cancer
Jacob, S., Davis, A. A., Gerratana, L., Velimirovic, M., Shah, A. N., Wehbe, F., Katam, N., Zhang, Q., Flaum, L., Siziopikou, K. P., Platanias, L. C., Gradishar, W. J., Behdad, A., Bardia, A. & Cristofanilli, M., Mar 1 2021, In: Clinical Cancer Research. 27, 5, p. 1361-1370 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In: npj Breast Cancer. 6, 1, 15.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Landscape of circulating tumour DNA in metastatic breast cancer
Davis, A. A., Jacob, S., Gerratana, L., Shah, A. N., Wehbe, F., Katam, N., Zhang, Q., Flaum, L., Siziopikou, K. P., Platanias, L. C., Gradishar, W. J., Behdad, A. & Cristofanilli, M., Aug 2020, In: EBioMedicine. 58, 102914.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
the International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In: npj Breast Cancer. 6, 1, 17.Research output: Contribution to journal › Article › peer-review
Open Access27 Scopus citations